Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis

NCT01676155 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01676155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01676155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2011
Completion date
Not reported
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

to compare the serum apoptosis-associated markers between patients with active tb and patients with ltbi, to evaluate the efficiency of apoptosis-associated markers to differentiate potential of active tb from ltbi